<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">
Log In

SmartTRAK Life Sciences News and Analysis Blog

Erin Dorgan

Senior Analyst, Spine and OrthoBiologics

Recent Posts

3 min read

NASS Biologic Interventions 2025: Spotlight on Allumin8

By Erin Dorgan on 5/20/25 9:30 AM

Allumin8 CEO Alyssa Huffman discusses the company's novel therapeutic hardware during an interview with SmartTRAK at the 2025 NASS Biologic Interventions.

Alyssa Huffman, CEO of Allumin8, discussed the company and its efforts to create a new product category of therapeutic hardware in an interview with SmartTRAK on May 9, 2025, at the 2025 North American Spine Society (NASS) Biologics Interventions meeting in Chicago, Illinois. The company is focused on treating over 200 unique bone disorders and diseases, and its first product is focused on the Spinal Hardware Market.

Click on the following video (8:49 min) to learn more. A link to download a complete transcript of the interview is also provided below.

 

SmartTRAK: Hi, this is Erin Dorgan, senior analyst here at SmartTRAK. I'm here today with Alyssa Huffman, CEO of ALLUMIN8. Alyssa, thank you for joining me today. Can you share a little bit more about your background and your role at ALLUMIN8?

Alyssa Huffman: Absolutely, Erin. Thanks for being here. I started in the clinic, then worked in the OR, went into sales, distribution. I worked my way into an executive function and then decided I was going to bet on myself. I have 30 years of experience throughout orthopedic spine biologics regenerative therapies.

That's awesome.

AH: And computer navigation.

Well, that's quite extensive. So we're here today at the NASS Biologic Interventions for Spinal Pathologies meeting. Why are you here with ALLUMIN8? What's the purpose for ALLUMIN8 presenting?

AH: Dr. Zorica Buser, she asked me to come and talk to the researchers and physicians about how to design a product that will actually commercialize and can get funded. There's a very different issue that's going on right now where products that only are a little bit, 1% to 3%, better than what's currently available on the market. There's a plethora of those, and so we have ...

Click the button below to download the complete transcript of our interview with Allumin8 CEO Alyssa Huffman, conducted by Erin Dorgan, SmartTRAK Senior Analyst.Get the Transcript
Continue Reading
2 min read

Clinical Evidence Poised to Redefine the Bone Replacement Market in 2025 and Beyond

By Erin Dorgan on 4/29/25 9:10 AM

SmartTRAK discusses key products and compelling clinical evidence that may impact the Bone Replacement Market in 2025 and beyond.

SmartTRAK looks at what’s on the horizon in 2025 and beyond and highlights the innovation and product advances that could shake up the US Market for Bone Replacement, which is projected to reach a 5-year CAGR of +3.8% by 2028. In this article, SmartTRAK details the recent growth factors/peptides bone grafts that received the FDA’s Breakthrough Device Designation (BDD) and significant milestones in product development in 2024. It also discusses new clinical evidence challenging the belief that autologous bone is the most efficacious graft material.

Curious which companies and products are making waves? This downloadable market outlook article covers, among others:

  • Cerapedics' investigational P-15 Peptide Enhanced Bone Graft
  • Medtronic’s Infuse bone graft
  • Theradaptive's OsteoAdapt SP bone graft
  • Bone Biologics' NB1 bone graft
  • Locate Bio's LDGraft bone graft 
  • Renovos' Renovite BMP-2 bone graft 
  • CBBio's NOVOSIS Putty
  • Amphix Bio's  drug-device combination product for bone regeneration
  • Kuros Biosciences' MagnetOs Granules bone graft

With new growth factor/peptides bone grafts progressing with their timelines to the market and clinical data demonstrating superiority over autograft, the Bone Replacement market is primed to grow in 2025 and the coming years.

Click the button below to download and read the complete "Clinical Evidence Poised to Redefine the Bone Replacement Market in 2025 and Beyond" Market Outlook article by SmartTRAK Erin Dorgan, Sr Analyst.Get the Article

Continue Reading
2 min read

Bone Replacement Trends for 2025

By Erin Dorgan on 3/10/25 2:54 PM

SmartTRAK will be attending AAOS 2025 this week. Join us at AAOS to explore our solution and discuss our roadmap for expanding into other orthopedic markets. Learn more about our Brand Tracker here or schedule time to Meet with Us at the show!

Topics: Orthopedics
Continue Reading
3 min read

Musculoskeletal New Ventures Conference 2024

By Erin Dorgan on 12/3/24 9:40 AM

New spine technologies "pushed the envelope" at MNVC

The Musculoskeletal New Ventures Conference (MNVC) is an annual meeting where early and late-stage companies present their ideas. This meeting occurred in Memphis, Tennessee, from October 28 - 30, with a broad mix of attendees, including surgeons, venture capitalists, the medical device industry and researchers. Forty companies presented this year, a record number for this meeting, focused exclusively on the musculoskeletal industry. In this article, SmartTRAK highlights six companies with new technologies to "push the envelope" in the US Spinal Hardware Market, which SmartTRAK estimates is growing at a 5-year CAGR of +4.7%.

This downloadable article provides an in-depth look at the following six companies' innovative new technologies:

Continue Reading
2 min read

NASS 2024: Highlights from the Annual Meeting in Chicago

By Erin Dorgan on 10/15/24 9:30 AM

New products and clinical data continue to grow the spinal hardware and bone replacement markets.

The North American Spine Society (NASS) was buzzing with new technologies at its 39th annual meeting in Chicago, September 25-28. Over 4,000 medical registrants and industry personnel attended this year’s meeting. This is the largest spine-focused meeting in the US, and it supports the spinal hardware and bone replacement markets. SmartTRAK estimates the spinal hardware market is poised to post a 5-yr CAGR of +4.7%, and the bone replacement market in spine is expected to reach a 5-year CAGR of +3.5%.

In this market perspective article, SmartTRAK highlights ...

  • Spine Hardware Refreshed-The Latest Product Innovations
    • Pedicle Screws
    • Disc Prep
  • Bone Replacement Market - New Products for DBM
    • The Data Race Continues
    • Product Innovations
  • A Strong Showing from Korean Manufacturers
    • New this year at NASS was the Korean SpineTech Pavilion, sponsored by the Korean Ministry of Health and Welfare and the Korean Health Industry Development Institute. This pavilion housed smaller companies at one booth to showcase ...

Click the button below to download and read the complete "NASS 2024 Annual Meeting Highlights" market perspective article by Erin Dorgan, SmartTRAK Senior Analyst, Spine.

Continue Reading
3 min read

SMISS 2024 - MIS Spine Continues to Grow

By Erin Dorgan on 10/8/24 9:28 AM

SmartTRAK takes a look at trends impacting the MIS Spine market.

The seventeenth Society of Minimally Invasive Spine Surgery (SMISS) Annual Forum was held in Las Vegas, Nevada, from September 5 to 7. It is the only US-based spine meeting dedicated to minimally invasive surgery (MIS). At this year’s meeting, the presenters focused on “innovate, adapt and evolve.”
 

In this article, SmartTRAK highlights key presentations and the latest trends from SMISS 2024 affecting the Spine Market. This includes what challenges still exist for MIS transforaminal lumbar interbody fusion (TLIF) procedures, considerations for surgeons learning the prone transpsoas (PTP) approach, indication expansion opportunities for cervical disc replacement (CDR) and factors that could disrupt the market for spine surgeons. SmartTRAK estimates these trends will contribute to the US MIS market 5-year CAGR of +7.0% by 2028. 

The topics covered include:

  • New Technologies Help Advance MIS TLIF Procedures
    • SmartTRAK estimates that MIS posterior procedures will reach 88K in 2028E, and over half of the interbody procedures are ... (read more)
  • Lateral Lumbar Interbody Procedures Growing in Mid-Single Digits
    • One of the fastest growing segments of the MIS Spine Market is Lateral Lumbar Interbody Fusion, which SmartTRAK estimates is growing with a 5-year CAGR of ... (read more)
  • Cervical Disc Replacement Indications Poised to Expand
    • SmartTRAK estimates that the CDR market is one of the fastest growth markets in Spine, with a projected 5-year revenue ... (read more)
  • ‘Innovator’s Dilemma’ Could Disrupt the Spine Market for Surgeons
    • Concluding the meeting with his presidential address, Sheeraz Qureshi, MD, MBA, Co-Chief of Hospital of Special Surgery Spine and an Attending Orthopedic Surgeon at HSS, shared his vision of the future of the Spine Market with ... (read more)

Click the button below to download and read the complete "SMISS 2024 - MIS Spine Continues to Grow" perspective article by Erin Dorgan, SmartTRAK Sr Analyst, Spine and Orthobiologics.

Topics: Spine
Continue Reading
  • There are no suggestions because the search field is empty.

Recent Articles